Cardiac failure in Chilean hospitals: Results of the National Registry of Heart Failure, ICARO;Insuficiencia cardíaca en hospitales chilenos: Resultados del Registro Nacional de Insuficiencia Cardíaca, Grupo ICARO

Revista Medica de Chile

Volumn 132, Issue 6, 2004, Pages 655-662

  Castro G, Pablo ^a,b   Vukasovic R, José Luis ^a   Garcés S, Eduardo ^a   Sepúlveda M, Luis ^a   Ferrada K, Marcela ^a   Alvarado O, Sergio ^a  

^a Depto Estud Multicentricos Soc C   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cardiac output, low; Heart diseases; Heart failure, congestive; Myocardial ischemia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CHILE; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DIET; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INFECTION; LENGTH OF STAY; MALE; MORTALITY; PATIENT COMPLIANCE; PRESCRIPTION; PROSPECTIVE STUDY; VALVULAR HEART DISEASE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILE; CHRONIC DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRECIPITATING FACTORS; PROSPECTIVE STUDIES; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 12444320262     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Heart Failure: evaluation and care of patients with left ventricular dysfunction. US Department of Health and Human Services. Publication No 94-0612, Maryland, 1994.
2. RODRÍGUEZ ARTALEJO F, GUALLAR-CASTILLÓN P, BANEGAS R, DEL REY J. Trends in hospitalization and mortality for heart failure in Spain. Eur Heart J 1997; 18: 1537-40.
3. SHARPE N. Management principles: much more to be gained. En: Heart failure management. London: Martin Dunitz, 2000.
4. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
5. HOBBS FDR, DAVIS RC, MCLEOD S, MARSHALL T, KENKRE J, LANCASHIRE R. Prevalence of Heart Failure in high risk groups. J Am Coll Cardiol 1998; 31: 5-85.
6. ERHARDT L, CLINE C. Community Management of Heart Failure 2000. En: Heart failure management. London: Martin Dunitz, 2000.
7. COHEN-SOLAL A, DESNOS M, DELAHAYE F, EMERIAN JP, HANANIA G. A national survey of heart failure in French hospitals. Eur Heart J 2000; 21: 763-769.
8. COWIE MR, MOSTERD A, WOOD DA, DECKERS JW, POOLE-WILSON PA, SUTTON GC ET AL. The epidemiology of heart failure. Eur Heart J 1991; 8: 208-25.
9. PHILBIN EF, ANDREOU C, ROCCO TA, LYNCH LJ, BAKER SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996; 77: 832-8.
10. European Society of Cardiology: WJ Remme and K Swedberg, Task Force for the Diagnosis and Treatment of Chronic Heart Failure. Eur Heart J 2001; 22: 1527-60.
11. POLANCZYK CA, NEWTON C, DEC GW, DI SALVO TG. Quality of care and hospital readmision in congestive heart failure: An explicit review process. J Cardiac Failure 2001; 7: 289-98.
12. GRUPO DE TRABAJO DE INSUFICIENCIA CARDÍACA DE LA SOCIEDAD ESPAÑOLA DE MEDICINA INTERNA (SEMI). La insuficiencia cardíaca en los servicios de medicina interna (estudio SEMI-IC). Med Clin (Barc) 2002; 118: 605-10.
13. THIERER J, IGLESIAS D, FERRANTE D, MARINO J, DIEZ M, ROLONG B ET AL. A. Registro nacional de internación por insuficiencia cardíaca. Factores responsables, evolución hospitalaria y predictores de mortalidad. Revista Argentina de Cardiología 2002; 70: 261-73.
14. THE DIGITALIS INVESTIGATION GROUP. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
15. THE CONSENSUS TRIAL STUDY GROUP. Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative north Scandinavian Enalapril Survival Study. N Eng J Med 1987; 316: 1429-35.
16. PITT B, ZANNAD F, CODY R, CASTAIGNE A, PÉREZ A, PALENSKY J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17.
17. CIBIS II INVESTIGATORS AND COMMITTEES. The cardiac insufficiency bisoprolol study (CIBIS-II): a randomized trial. Lancet 1998; 353: 9-13.
18. FORTEZA-REY J. Comorbilidad e insuficiencia cardíaca. Rev Clin Esp 2001; 201 (Supl 1): 16-21.
19. KASPER EK, GERNSTENBLITH G, HEFTER G, VAN ANDEN E, BRINKER JA, THIEMANN DR ET AL. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Col Cardiol 2002; 39: 471-80.
20. PHILBIN EF, DEC GW, JENKINS PL, DISALVO TG. Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol 2001; 87: 1367-71.
21. TSUYUKI RT, MCKELVIE RS, ARNOLD MO, AVEZUM A, BARRETTO AC, CARVALHO AC ET AL. Acute Precipitants of Congestive Heart Failure Exacerbations. Arch Intern Med 2001; 161: 2337-42.
22. CLARKE K, GRAY D, HAMPTON J. Evidence of inadequate investigation and treatment of patients with heart failure. B Heart J 1994; 71: 584-7.
23. CUFFE MS, CALIFF RM, ADAMS KF, BENZA R, BOURGE R, COLUCCI WS ET AL. Outcomes of a Prospective Trial of Intravenous Milrinone for Exarcebations of Chronic Heart Failure (OPTIME-CHF) Investigators. JAMA 2002; 287: 1578-80.
24. BELLOTTI P, BADANO LP, ACQUARONE N, GRILLO R, LOPINTO G, MAGGIONI AP. Speciality related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. Eur Heart J 2001; 22: 596-604.